anagrelide
Generic: ANAGRELIDE HYDROCHLORIDE·Brand: AGRYLIN, ANAGRELIDE HYDROCHLORIDE, Agrylin
anagrelide: 1 clinical trial tracked.
anagrelide evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about anagrelide, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Clinical Trial Registry Records (1)
A Phase 3, Randomized, Open-label, Active-Comparator-Controlled Clinical Study to Evaluate the Safety and Efficacy of Bomedemstat (MK-3543/IMG-7289) Versus Best Available Therapy (BAT) in Participants With Essential Thrombocythemia Who Have an Inadequate Response to or Are Intolerant of Hydroxyurea
Primary endpoint: Durable Clinicohematologic Response (DCHR) Rate
InterventionalRandomizedsingle340 targetStarted 2023-12Completion 2028-0850 sites · Argentina, Australia, Belgium, Canada…Merck Sharp & Dohme LLC